Osteoarthritis (OA) of the knee is a common complex disorder resulting in joint disability with known constitutional and environmental risk factors for development and progression, such as age, obesity, hormonal status, bone density, physical activity and past history of trauma. 1 Knee OA, also has an important genetic component, 2 and several studies have investigated the role of candidate genes in the risk of hip and knee OA. Several genes with common polymorphisms consistently affecting risk of OA have been reported to date. [3] [4] [5] [6] [7] [8] However, the genetic variants involved are not mutants with large attributable risks. Rather, the increased risks for carrying a predisposing genetic variant appear to be fairly modest, with most of them having odds ratios between 1.3 and 2.0. If an individual carries risk variants at several genes, does his/her risk of OA increase in proportion, or do genetic risks remain modest when compared with environmental/constitutional risk factors such as obesity and past history of trauma?
To answer this question we have combined the previously published genotypes of 36 variants on 17 genes in a multi-centre case-control study of knee OA. Variation at all the genes included in this study have been reported to be associated with risk of knee or hip OA in at least one independent study. 5 6 We assessed the risk of OA for individuals carrying several gene variants associated with disease susceptibility compared to individuals who carried few or none. Because several of the genes included (eg, FRZB, BMP2) 5 6 have been reported to be associated only or predominantly in women, and the prevalence of OA is higher in females, all analyses have been performed separately in each gender.
SUBJECTS AND METHODS
Subjects for this study have been described elsewhere. 6 
Genotypes
The genotyping data included in this study have been previously reported. For each SNP we identified the allele that was more common among cases than among controls and assigned a value of 1 to the homozygote carrying two copies of such allele, 0.5 to the heterozygote and 0 for the lower risk homozygote. The genes and SNPs included are shown in table 1.
Set association
This method is used to find a set of SNPs that are jointly associated with disease by computing an association statistic for each SNP ie, a x 2 for a 263 table, where the two rows correspond to cases and controls, and the three columns refer to SNP genotypes. Markers are then ordered by the size of their test statistics, and sums are formed sequentially, starting with the largest test statistic and gradually adding one after another SNP and sums, S, are formed sequentially, starting with the largest test statistic and gradually adding one after another SNP. S i is the sum of the i largest test statistics for the SNPs. For each S i , an associated significance level is computed with permutation testing (10 000 replicates). Only those SNPs that are significantly associated as part of a set (having taken into account any lack of independence between markers) result in a p value ,0.05 after correcting for multiple testing. The S statistic software available at http://www.genemapping.cn/sumstat.html was used. 9 This method has been shown to have consistently higher statistical power than individual marker associations under a range of simulated models. 11 Although set association can incorporate multiplicative effects, no interactions have been reported in the literature for these genes and no such exploratory analyses were undertaken.
Logistic regression
In order to combine all the significant SNPs resulting from the set association analysis into a single variable (not part of the set association method), we then fitted a logistic regression model. As not all significant markers are expected to contribute equally to disease risk, in order not to dilute the information on those The control frequency refers to the combined male and female population of the present study. genes that have a larger influence on risk of OA, the coefficients from the logistic regression were used as weights for the significant SNPs to generate a new ''genetic risk'' variable. The distribution was standardised to have mean = 0 and SD = 1. Odds ratios and 95% CI were derived from the logistic regression results. The genetic risk distribution between cases and controls was also compared using a Wilcoxon-rank test with a continuity correction. Analyses were carried out in S-Plus 6.0 (Insightful Corp, Seattle, Washington, USA).
Concise report

RESULTS
The set association method was used to identify the SNPs significantly contributing to knee OA risk while adjusting for multiple testing. 9 The set of markers were then included in a logistic regression and the coefficients from the model fitted to assign a weight to each genotype.
The final models fitted, standardised to have a mean of 0 and a variance of 1, were:
Genetic risk (women) = (1/0.9829) 6 ((0.3898 6 adam_int) + (0.5113 6 adam_504) + (0.4825 6 aact) + (1.69266 cilp_3p) + (1.4256 6tna_106) + (1.2562 6frzb_200) + (0.7132 6frzb_324) + (1.7504 6 cilp_395) + (1.0828 6 aspn_5p) + (1.3776 6 aspn_3p1) + (0.9611 6 bmp2_87) + (0.8695 6 esr_594)-4.59064).
Genetic risk (men) = (1/0.8338) 6 ((1.9538 6 cilp_3p) + (0.5236 6 adam_int) + (0.3414 6 vdr_365) + (0.3894 6 esr1_325) 6 aspn_5p)-3.5814) .
Where adam_int, adam_504 etc denote the genotype (0, 0.5, 1) of the SNP listed in table 1 coded as described under the methods section. Figure 1 shows the frequency distribution of the genetic risk. 
DISCUSSION
The data shown here indicate that it is possible to identify individuals at high risk of knee OA using genotype data. Although family and epidemiological studies have consistently indicated an important genetic contribution to OA, to date no single large genetic effect has been found. From a biological point of view these results confirm that the genetic risk to knee OA is likely to be due to the sum of many loci making a small contribution each. Consistent with the gender differences previously reported 5 these data suggest that by using genderspecific genetic factors it may be possible to predict a high risk of knee OA both in men and women.
All the genes included in this model have been reported to be significantly associated with clinical or radiographic features of knee or hip OA in at least one independent study. The odds ratios obtained using the genetic risk variable are comparable than those reported for obesity or knee injury by some studies. [12] [13] [14] For example the odds ratios for obesity/BMI as a risk factor range from 3.0 12 13 to 18.0 12 14 and the odds ratios for knee injury range from 3.0 for bilateral disease 12 There are some limitations to the present study. First, the genes and all the model parameters were derived from within the same population. Therefore, although all the genes have been independently associated with OA before, we cannot assess the value of these data in predicting knee OA risk without testing this model first in an independent sample. In addition, there are other candidate genes that have been consistently associated with OA that were not genotyped as part of this study (eg, interleukin genes) 7 8 and that could result in improved prediction.
If these data are replicated in independent studies, it should be possible to indeed use genetic information for risk assessment. An important insight from this study is that the inclusion of more genes as genome-wide association scans and new candidates become available is likely to improve prediction of risk of knee OA to a level where it can be clinically useful. 
